✦ LIBER ✦

Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse

✍ Scribed by Nadia Iovieno; Adrienne van Nieuwenhuizen; Alisabet Clain; Lee Baer; Andrew A. Nierenberg

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 109 KB
Volume: 28
Category: Article
ISSN: 1091-4269
DOI: 10.1002/da.20768

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for relapse after remission

Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression

✍ Roni B. Cohen; Paulo S. Boggio; Felipe Fregni 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 2 views

## Background: Several studies have shown that repetitive transcranial magnetic stimulation (rtms) treatment is associated with a significant antidepressant effect that can last for several months. ## Methods: To investigate the mean remission time and the predictors associated with its duration;

Increased symptoms of attention deficit

Increased symptoms of attention deficit hyperactivity disorder and major depressive disorder symptoms in nail-patella syndrome: Potential association with LMX1B loss-of-function

✍ Carmen López-Arvizu; Elizabeth P. Sparrow; Michael J Strube; Chris Slavin; Carol 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Suicidal risk in young adult offspring o

Suicidal risk in young adult offspring of mothers with bipolar or major depressive disorder: a longitudinal family risk study

✍ Bonnie Klimes-Dougan; Chih-Yuan S. Lee; Donna Ronsaville; Pedro Martinez 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

## Abstract Recent evidence has highlighted suicidal risk associated with bipolar disorder (BD). Using a family risk approach, the goal of this study was to evaluate suicidal thoughts and behaviors longitudinally from childhood to young adulthood in children of mothers with BD, Major depressive dis

Validation of the Depression and Somatic

Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder

✍ Ching-I Hung; Shuu-Jiun Wang; Chia-Yih Liu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Assessment of depressive symptoms and fu

Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol

✍ Tina Marie Myers Oakes; Adam L. Myers; Lauren B. Marangell; Jonna Ahl; Apurva Pr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 3 views

Objective Return of functional ability is a central goal in the treatment of major depressive disorder. We conducted two trials with the same protocol that was designed to assess functioning after 8 Weeks of treatment with duloxetine. Methods The a priori primary outcome was improvement in the Hamil